M&A Deal Summary |
|
---|---|
Date | 2020-10-07 |
Target | Alsendo |
Sector | Internet Software and Services |
Buyer(s) | Abris Capital Partners |
Sellers(s) | 21 Invest |
Deal Type | Secondary Buyout |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 2007 |
Size | Small |
Type | Sector Agnostic |
Abris Capital Partners is a private equity firm focused on opportunities in Central and Eastern Europe. Abris targets situations where it can commit €30 to €75 million. Prospective businesses generally lead their markets, have 'significant' growth potential (organic or through consolidation), strong management, and predictable cash-flows. Abris Capital Partners was established in 2007 and is based in Warsaw.
DEAL STATS | # |
---|---|
Overall | 28 of 31 |
Sector (Internet Software and Services) | 1 of 1 |
Type (Secondary Buyout) | 2 of 2 |
Country (Poland) | 17 of 19 |
Year (2020) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-02-26 |
GetBack
Wroclaw, Poland GetBack is active in debt recovery industry. GetBack acquires on its own balance sheet and on behalf of third parties, portfolios of Non-Performing Loans (“NPL”) mainly from banks, but also from telecoms and utilities. GetBack was founded in 2012 and is based in Wroclaw, Poland. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-11-26 |
Scanmed
Warsaw, Poland Scanmed is a healthcare network operator. Scanmed offers its patients access to comprehensive treatment methods, technologically advanced and high-quality medical equipment, and experienced specialists to facilitate their recovery. The company operates in 42 locations across Poland, providing primary healthcare and specialist consultations, advanced diagnostics, and hospital treatment. Scanmed is based in Warsaw, Poland. |
Buy | zł340M |
Category | Private Equity Firm |
---|---|
Founded | 1992 |
PE ASSETS | 1.0B EUR |
Size | Large |
Type | Sector Agnostic |
21 Invest is a private equity firm that targets investments in growth-oriented, middle-market Italian, French, and Polish companies operating in a variety of industries. The Firm invests in French businesses through 21 Centrale Partners, Italian companies through 21 Partners SGR, and Polish companies through 21 Concordia. The Firm targets transactions requiring at least €10 million of capital typically in the form of development capital for growth companies, buyout capital for managers, or replacement capital for companies facing succession issues or needing shareholder liquidity. 21 Invest was founded in 1992 and is based in Treviso, Italy.
DEAL STATS | # |
---|---|
Overall | 32 of 37 |
Sector (Internet Software and Services) | 1 of 1 |
Type (Secondary Buyout) | 18 of 23 |
Country (Poland) | 1 of 1 |
Year (2020) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-07-04 |
Laboratoire Gifrer - Dacudoses & Novoptine
Décines-Charpieu, France Dacudoses is a reimbursed brand of the French ophthalmic antiseptic segment, prescribed by ophthalmologists and general practitioners. Dacudoses is commonly used as an eyewash in case of light conjunctivitis and/or infections, benefitting from a very strong brand recognition in France. Novoptine is an over-the-counter antiseptic collyrium used to treat eye infections and conjunctivitis. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-12-10 |
Poligof
Pieve Fissiraga, Italy Poligof is a manufacturer of backsheet for hygiene disposable products. Poligof operates production facilities in Italy, Russia, India and sells its products to the global market. Poligof projects and activities have always been focused on growth and expansion, being a company that invests in innovation, development, technology, and production efficiency. Poligof was formed in 1979 and is based in Pieve Fissiraga, Italy. |
Sell | - |